341 related articles for article (PubMed ID: 29958877)
21. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.
Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Heller C; Klingebiel T
Transfusion; 2009 Sep; 49(9):1987-95. PubMed ID: 19497056
[TBL] [Abstract][Full Text] [Related]
22. Treatment for hereditary angioedema with normal C1-INH and specific mutations in the F12 gene (HAE-FXII).
Bork K; Wulff K; Witzke G; Hardt J
Allergy; 2017 Feb; 72(2):320-324. PubMed ID: 27905115
[TBL] [Abstract][Full Text] [Related]
23. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.
Bouillet L; Boccon-Gibod I; Launay D; Gompel A; Kanny G; Fabien V; Fain O;
Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922
[TBL] [Abstract][Full Text] [Related]
24. Training hereditary angioedema patients to self-administer intravenous C1 esterase inhibitor concentrate.
Shapiro RS; Zacek L
J Infus Nurs; 2014; 37(4):284-90. PubMed ID: 24983261
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of long term treatments of type I hereditary angioedema in a Turkish family.
Akoglu G; Kesim B; Yildiz G; Metin A
An Bras Dermatol; 2017; 92(5):655-660. PubMed ID: 29166502
[TBL] [Abstract][Full Text] [Related]
26. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
Zanichelli A; Wu MA; Andreoli A; Mansi M; Cicardi M
Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506
[TBL] [Abstract][Full Text] [Related]
27. Treatment of patients with hereditary angioedema with the c.988A>G (p.Lys330Glu) variant in the plasminogen gene.
Bork K; Wulff K; Witzke G; Machnig T; Hardt J
Orphanet J Rare Dis; 2020 Feb; 15(1):52. PubMed ID: 32066472
[TBL] [Abstract][Full Text] [Related]
28. National audit of a hereditary and acquired angioedema cohort in New Zealand.
Lindsay K; Chua I; Jordan A; Stephens S
Intern Med J; 2022 Dec; 52(12):2124-2129. PubMed ID: 34346157
[TBL] [Abstract][Full Text] [Related]
29. Hereditary angioedema: diagnosis and management-a perspective for the dermatologist.
Parish LC
J Am Acad Dermatol; 2011 Oct; 65(4):843-850. PubMed ID: 21550133
[TBL] [Abstract][Full Text] [Related]
30. Demographic and clinical characteristics of patients with hereditary angioedema in Canada.
Lee EY; Hsieh J; Caballero T; McCusker C; Kanani A; Lacuesta G; Borici-Mazi R; Waserman S; Betschel S
Ann Allergy Asthma Immunol; 2022 Jan; 128(1):89-94.e1. PubMed ID: 34298173
[TBL] [Abstract][Full Text] [Related]
31. Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement.
Riedl MA; Li HH; Cicardi M; Harper JR; Relan A
Allergy Asthma Proc; 2017 Nov; 38(6):462-466. PubMed ID: 28903805
[TBL] [Abstract][Full Text] [Related]
32. Hereditary angioedema: a clinical review for the otolaryngologist.
Anon JB
Ear Nose Throat J; 2011 Jan; 90(1):32-9. PubMed ID: 21229509
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency.
Bork K; Bernstein JA; Machnig T; Craig TJ
J Emerg Med; 2016 Apr; 50(4):567-80.e1. PubMed ID: 26826769
[TBL] [Abstract][Full Text] [Related]
34. Hereditary Angioedema: A Review of the Current and Evolving Treatment Landscape.
Betschel SD; Banerji A; Busse PJ; Cohn DM; Magerl M
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2315-2325. PubMed ID: 37116793
[TBL] [Abstract][Full Text] [Related]
35. Emergency Department Management of Hereditary Angioedema Attacks: Patient Perspectives.
Otani IM; Christiansen SC; Busse P; Camargo CA; Zuraw BL; Riedl MA; Banerji A
J Allergy Clin Immunol Pract; 2017; 5(1):128-134.e4. PubMed ID: 27665386
[TBL] [Abstract][Full Text] [Related]
36. Management of Children With Hereditary Angioedema Due to C1 Inhibitor Deficiency.
Frank MM; Zuraw B; Banerji A; Bernstein JA; Craig T; Busse P; Christiansen S; Davis-Lorton M; Li HH; Lumry WR; Riedl M;
Pediatrics; 2016 Nov; 138(5):. PubMed ID: 27940765
[TBL] [Abstract][Full Text] [Related]
37. New treatment options for acute edema attacks caused by hereditary angioedema.
Thomas MC; Shah S
Am J Health Syst Pharm; 2011 Nov; 68(22):2129-38. PubMed ID: 22058099
[TBL] [Abstract][Full Text] [Related]
38. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.
Bork K
Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050
[TBL] [Abstract][Full Text] [Related]
39. Discrepancies between guidelines and international practice in treatment of hereditary angioedema.
Dispenza MC; Craig TJ
Allergy Asthma Proc; 2012; 33(3):241-8. PubMed ID: 22584193
[TBL] [Abstract][Full Text] [Related]
40. Assessment of hereditary angioedema treatment risks.
Kalaria S; Craig T
Allergy Asthma Proc; 2013; 34(6):519-22. PubMed ID: 24169059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
